Geode Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8M Sell
2,222,962
-7,804
-0.3% -$41.4K ﹤0.01% 2252
2025
Q1
$19.8M Buy
2,230,766
+87,897
+4% +$780K ﹤0.01% 1910
2024
Q4
$29.4M Sell
2,142,869
-11,166
-0.5% -$153K ﹤0.01% 1747
2024
Q3
$59M Buy
2,154,035
+21,220
+1% +$581K ﹤0.01% 1318
2024
Q2
$52.2M Buy
2,132,815
+116,443
+6% +$2.85M ﹤0.01% 1335
2024
Q1
$43M Buy
2,016,372
+144,515
+8% +$3.08M ﹤0.01% 1456
2023
Q4
$35.8M Buy
1,871,857
+144,973
+8% +$2.78M ﹤0.01% 1548
2023
Q3
$27.7M Buy
1,726,884
+62,037
+4% +$995K ﹤0.01% 1615
2023
Q2
$38.6M Buy
1,664,847
+60,740
+4% +$1.41M ﹤0.01% 1421
2023
Q1
$37.3M Buy
1,604,107
+78,333
+5% +$1.82M ﹤0.01% 1390
2022
Q4
$22.1M Buy
1,525,774
+55,004
+4% +$798K ﹤0.01% 1707
2022
Q3
$28.1M Buy
1,470,770
+25,478
+2% +$486K ﹤0.01% 1508
2022
Q2
$26.3M Sell
1,445,292
-2,665
-0.2% -$48.4K ﹤0.01% 1560
2022
Q1
$36.5M Buy
1,447,957
+18,879
+1% +$476K ﹤0.01% 1473
2021
Q4
$39.4M Buy
1,429,078
+49,362
+4% +$1.36M ﹤0.01% 1481
2021
Q3
$44.6M Buy
1,379,716
+15,951
+1% +$515K 0.01% 1379
2021
Q2
$41.7M Buy
1,363,765
+100,088
+8% +$3.06M 0.01% 1466
2021
Q1
$38.5M Buy
1,263,677
+119,711
+10% +$3.65M 0.01% 1438
2020
Q4
$22.6M Buy
1,143,966
+21,092
+2% +$417K ﹤0.01% 1645
2020
Q3
$14.6M Sell
1,122,874
-22,827
-2% -$298K ﹤0.01% 1737
2020
Q2
$13M Buy
1,145,701
+41,075
+4% +$466K ﹤0.01% 1776
2020
Q1
$15.8M Buy
1,104,626
+51,073
+5% +$731K ﹤0.01% 1458
2019
Q4
$28.7M Buy
1,053,553
+43,571
+4% +$1.19M 0.01% 1323
2019
Q3
$28.9M Buy
1,009,982
+11,539
+1% +$330K 0.01% 1233
2019
Q2
$27.7M Buy
998,443
+71,670
+8% +$1.99M 0.01% 1253
2019
Q1
$30.8M Buy
926,773
+47,324
+5% +$1.57M 0.01% 1120
2018
Q4
$25.6M Buy
879,449
+103,528
+13% +$3.01M 0.01% 1109
2018
Q3
$35.7M Buy
775,921
+42,900
+6% +$1.97M 0.01% 1011
2018
Q2
$27.4M Buy
733,021
+56,762
+8% +$2.12M 0.01% 1120
2018
Q1
$20M Buy
676,259
+59,463
+10% +$1.76M 0.01% 1263
2017
Q4
$21.2M Sell
616,796
-42,631
-6% -$1.46M 0.01% 1233
2017
Q3
$23.9M Buy
659,427
+5,552
+0.8% +$201K 0.01% 1110
2017
Q2
$16.9M Sell
653,875
-7,432
-1% -$192K 0.01% 1319
2017
Q1
$12.7M Buy
661,307
+19,251
+3% +$370K 0.01% 1467
2016
Q4
$10.7M Buy
642,056
+18,428
+3% +$307K 0.01% 1518
2016
Q3
$12.8M Buy
623,628
+62,600
+11% +$1.29M 0.01% 1324
2016
Q2
$17.2M Buy
561,028
+33,436
+6% +$1.02M 0.01% 1048
2016
Q1
$19.7K Buy
527,592
+37,842
+8% +$1.42K 0.01% 939
2015
Q4
$21.1M Buy
489,750
+7,092
+1% +$306K 0.01% 862
2015
Q3
$18.1M Buy
482,658
+26,589
+6% +$997K 0.01% 943
2015
Q2
$15.5M Buy
456,069
+54,590
+14% +$1.86M 0.01% 1101
2015
Q1
$14.2M Buy
401,479
+8,167
+2% +$289K 0.01% 1123
2014
Q4
$13.4M Buy
393,312
+5,482
+1% +$187K 0.01% 1105
2014
Q3
$15M Buy
387,830
+3,425
+0.9% +$132K 0.01% 1004
2014
Q2
$15M Buy
384,405
+9,858
+3% +$384K 0.01% 1006
2014
Q1
$12.8M Sell
374,547
-1,413
-0.4% -$48.3K 0.01% 1077
2013
Q4
$7.89M Sell
375,960
-116,346
-24% -$2.44M 0.01% 1370
2013
Q3
$11.6M Buy
492,306
+32,335
+7% +$760K 0.01% 974
2013
Q2
$12.4M Buy
+459,971
New +$12.4M 0.01% 839